Effectiveness and Safety of Eptinezumab in Episodic and Chronic Migraine Headache in the UAE: A Retrospective Study

INTRODUCTION: Eptinezumab is a humanized IgG1 immunoglobulin monoclonal antibody administered intravenously as a preventative migraine treatment. Previously conducted randomized, double-blind, placebo-controlled trials exhibited significant reductions in monthly migraine frequency among adults exper...

Descripción completa

Detalles Bibliográficos
Autores principales: Bader, Yazan, Suliman, Reem, Harb, Mohamad, Santos, Vanessa, Al Qaisi, Ibrahim, Alsaadi, Taoufik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444733/
https://www.ncbi.nlm.nih.gov/pubmed/37418120
http://dx.doi.org/10.1007/s40120-023-00521-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444733/
https://www.ncbi.nlm.nih.gov/pubmed/37418120
http://dx.doi.org/10.1007/s40120-023-00521-5

Ejemplares similares